Parallel Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Parallel Advisors's LMAT Position: Q3 2026 in Review
Parallel Advisors reduced its LeMaitre Vascular (LMAT) stake by 38% in Q3 2026, selling an estimated $443 and leaving 8 shares worth $661. The position accounts for ﹤0.01% of the portfolio, ranked #3852.
Parallel Advisors first reported a position in LMAT in Q4 2019 and has held it in 21 quarters since. The position peaked at $8.49K in Q1 2024. 98 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Parallel Advisors held 8 shares of LeMaitre Vascular worth $661 as of Q3 2026.
- Parallel Advisors sold 5 LeMaitre Vascular shares in Q3 2026, an estimated $443.
- LeMaitre Vascular made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3852 holding.
- Parallel Advisors first reported a position in LeMaitre Vascular in Q4 2019 and has held it in 21 quarters since.
- Parallel Advisors's LeMaitre Vascular position peaked at $8.49K in Q1 2024.
- 98 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.